SCHEMBL25281113

SCHEMBL25281113

CC1=CN(C(=O)O)C(COC(=O)c2ccccc2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.54
CHRNA4 P43681 5/20 0.54
CHRNA7 P36544 4/20 0.54
CHRNA5 P30532 3/20 0.54
NPC1 O15118 2/20 0.44
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
LMNA P02545 1/20 0.43
TDP1 Q9NUW8 2/20 0.41
RAB9A P51151 1/20 0.41
CES2 O00748 1/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SCN1A P35498 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30466113 1.00 CHRNB2 (0.54) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL25694060 0.86 CHRNB2 (0.49) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL23629606 0.73 CHRNB2 (0.52) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL25235927 0.71 CHRNB2 (0.53) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL18588003 0.70 CHRNB2 (0.52) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL18588004 0.70 CHRNB2 (0.52) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL19615663 0.70 CHRNB2 (0.52) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL18587701 0.70 CHRNB2 (0.52) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL30959853 0.70 CHRNB2 (0.63) CHRNB2CHRNA4CHRNA7CHRNA5NPC1
SCHEMBL25895867 0.70 CHRNB2 (0.63) CHRNB2CHRNA4CHRNA7CHRNA5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed